BioRestorative Therapies Analyst Ratings
BioRestorative Therapies Analyst Ratings
While ratings are subjective and will change, the latest BioRestorative Therapies (BRTX) rating was a reiterated with a price target of $0.00 to $15.00. The current price BioRestorative Therapies (BRTX) is trading at is $2.56, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 486.99% | Roth MKM | → $15 | Reiterates | Buy → Buy |
| 12/07/2022 | 486.99% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 09/28/2022 | 134.8% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
| 12/01/2021 | 1347.91% | Roth Capital | → $37 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/14/2023 | 486.99% | Roth MKM | → 15 美元 | 重申 | 購買 → 購買 |
| 2022 年 7 月 12 日 | 486.99% | 羅斯資本 | → 15 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 9 月 28 日 | 134.8% | Maxim 集團 | → 6 美元 | 啓動覆蓋開啓 | → 購買 |
| 12/01/2021 | 1347.91% | 羅斯資本 | → 37 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for BioRestorative Therapies (BRTX)?
生物修復療法（BRTX）的目標價格是多少？
The latest price target for BioRestorative Therapies (NASDAQ: BRTX) was reported by Roth MKM on August 14, 2023. The analyst firm set a price target for $15.00 expecting BRTX to rise to within 12 months (a possible 486.99% upside). 3 analyst firms have reported ratings in the last year.
Roth MKM於2023年8月14日公佈了生物恢復療法（納斯達克股票代碼：BRTX）的最新目標價格。該分析公司將目標股價定爲15.00美元，預計BRTX將在12個月內升至12個月內（可能上漲486.99％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for BioRestorative Therapies (BRTX)?
分析師對生物修復療法（BRTX）的最新評級是多少？
The latest analyst rating for BioRestorative Therapies (NASDAQ: BRTX) was provided by Roth MKM, and BioRestorative Therapies reiterated their buy rating.
生物恢復療法（納斯達克股票代碼：BRTX）的最新分析師評級由Roth MKM提供，BioRestorative Therapis重申了買入評級。
When is the next analyst rating going to be posted or updated for BioRestorative Therapies (BRTX)?
生物修復療法（BRTX）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioRestorative Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioRestorative Therapies was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與生物恢復療法的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。生物修復療法的最新評級是在2023年8月14日提交的，因此你應該預計下一個評級將在2024年8月14日左右公佈。
Is the Analyst Rating BioRestorative Therapies (BRTX) correct?
分析師對生物修復療法 (BRTX) 的評級是否正確？
While ratings are subjective and will change, the latest BioRestorative Therapies (BRTX) rating was a reiterated with a price target of $0.00 to $15.00. The current price BioRestorative Therapies (BRTX) is trading at is $2.56, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的生物修復療法（BRTX）評級，目標價爲0.00美元至15.00美元。生物恢復療法（BRTX）目前的交易價格爲2.56美元，在分析師的預測區間內。
